A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
06 07 2022
Historique:
received: 10 11 2021
accepted: 24 06 2022
entrez: 6 7 2022
pubmed: 7 7 2022
medline: 9 7 2022
Statut: epublish

Résumé

We are amid the historic coronavirus infectious disease 2019 (COVID-19) pandemic. Imbalances in the accessibility of vaccines, medicines, and diagnostics among countries, regions, and populations, and those in war crises, have been problematic. Nanobodies are small, stable, customizable, and inexpensive to produce. Herein, we present a panel of nanobodies that can detect the spike proteins of five SARS-CoV-2 variants of concern (VOCs) including Omicron. Here we show via ELISA, lateral flow, kinetic, flow cytometric, microscopy, and Western blotting assays that our nanobodies can quantify the spike variants. This panel of nanobodies broadly neutralizes viral infection caused by pseudotyped and authentic SARS-CoV-2 VOCs. Structural analyses show that the P86 clone targets epitopes that are conserved yet unclassified on the receptor-binding domain (RBD) and contacts the N-terminal domain (NTD). Human antibodies rarely access both regions; consequently, the clone buries hidden crevasses of SARS-CoV-2 spike proteins that go undetected by conventional antibodies.

Identifiants

pubmed: 35794202
doi: 10.1038/s42003-022-03630-3
pii: 10.1038/s42003-022-03630-3
pmc: PMC9257560
doi:

Substances chimiques

Antibodies, Viral 0
Membrane Glycoproteins 0
Single-Domain Antibodies 0
Spike Glycoprotein, Coronavirus 0
Viral Envelope Proteins 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

669

Informations de copyright

© 2022. The Author(s).

Références

Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
Acta Crystallogr D Biol Crystallogr. 2013 Jul;69(Pt 7):1204-14
pubmed: 23793146
Nature. 2021 May;593(7857):136-141
pubmed: 33706364
Cell. 2021 May 27;184(11):2939-2954.e9
pubmed: 33852911
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):22-5
pubmed: 20057045
Nature. 1993 Jun 3;363(6428):446-8
pubmed: 8502296
Cell. 2021 Jun 24;184(13):3426-3437.e8
pubmed: 33991487
Sci Rep. 2020 Dec 22;10(1):22370
pubmed: 33353972
Cell. 2021 Aug 5;184(16):4203-4219.e32
pubmed: 34242577
Cell. 2022 Feb 3;185(3):447-456.e11
pubmed: 35026151
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67
pubmed: 21460454
Cell. 2020 Jul 9;182(1):73-84.e16
pubmed: 32425270
Nature. 2021 May;593(7857):142-146
pubmed: 33780970
Cell. 2021 Jun 10;184(12):3086-3108
pubmed: 34087172
Science. 2021 Feb 12;371(6530):681-682
pubmed: 33574203
Nature. 2021 Apr;592(7854):438-443
pubmed: 33690265
Cell. 2022 Jun 9;185(12):2103-2115.e19
pubmed: 35568035
Trends Microbiol. 2021 Mar;29(3):195-203
pubmed: 33446406
Nature. 2022 Feb;602(7898):664-670
pubmed: 35016195
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Nat Protoc. 2014 Mar;9(3):674-93
pubmed: 24577359
J Struct Biol. 2015 Nov;192(2):216-21
pubmed: 26278980
Science. 2021 Aug 6;373(6555):
pubmed: 34168071
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
IUCrJ. 2020 Feb 11;7(Pt 2):253-267
pubmed: 32148853
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Nature. 2022 Mar;603(7902):679-686
pubmed: 35042229
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Cancer Res. 2021 Aug 1;81(15):4124-4132
pubmed: 34035084
Science. 2007 Jun 15;316(5831):1615-8
pubmed: 17569864
Trends Genet. 2000 Jun;16(6):276-7
pubmed: 10827456
Nature. 2022 Feb;602(7898):671-675
pubmed: 35016199
J Virol. 2002 Sep;76(17):8875-89
pubmed: 12163607
Nature. 2022 Mar;603(7902):706-714
pubmed: 35104837
Cell. 2020 Nov 12;183(4):1043-1057.e15
pubmed: 32970989
Nat Struct Mol Biol. 2019 Jun;26(6):481-489
pubmed: 31160783
Cell. 2022 Mar 3;185(5):860-871.e13
pubmed: 35120603
Proc Natl Acad Sci U S A. 2020 Mar 31;117(13):7001-7003
pubmed: 32165541
Nature. 2022 Apr;604(7906):553-556
pubmed: 35240676
Cell. 2020 May 28;181(5):1004-1015.e15
pubmed: 32375025
J Transl Med. 2014 Dec 20;12:352
pubmed: 25526777
Cell. 2021 Jul 22;184(15):3936-3948.e10
pubmed: 34192529
BioDrugs. 2020 Feb;34(1):11-26
pubmed: 31686399
Nat Struct Mol Biol. 2020 Sep;27(9):846-854
pubmed: 32661423
Nat Rev Immunol. 2021 Feb;21(2):73-82
pubmed: 33340022
Bioinformatics. 2010 Oct 1;26(19):2460-1
pubmed: 20709691
Sci Rep. 2019 May 9;9(1):7122
pubmed: 31073151
Science. 2021 Feb 12;371(6530):
pubmed: 33436526
Nat Med. 2021 May;27(5):917-924
pubmed: 33772244
Science. 2022 Feb 18;375(6582):760-764
pubmed: 35050643
Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
PLoS Pathog. 2014 Dec 18;10(12):e1004552
pubmed: 25522326
J Mol Biol. 2007 Sep 21;372(3):774-97
pubmed: 17681537
J Gene Med. 2005 Mar;7(3):354-65
pubmed: 15619290
Nature. 2011 Jan 13;469(7329):175-80
pubmed: 21228869
Science. 2021 Apr 30;372(6541):525-530
pubmed: 33727252
Sci Rep. 2021 Feb 8;11(1):3318
pubmed: 33558635
Science. 1988 May 20;240(4855):1041-3
pubmed: 3285471
Nat Struct Mol Biol. 2008 Nov;15(11):1184-91
pubmed: 18836454
Science. 2020 Dec 18;370(6523):1479-1484
pubmed: 33154108
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
J Mol Biol. 2009 Sep 25;392(3):787-802
pubmed: 19631658
Cell. 2021 Mar 4;184(5):1171-1187.e20
pubmed: 33621484
Science. 2021 Jul 9;373(6551):
pubmed: 34035154
PLoS One. 2016 Oct 5;11(10):e0163962
pubmed: 27706213
Nature. 2021 Dec;600(7889):512-516
pubmed: 34544114
Nature. 2021 Jul;595(7866):278-282
pubmed: 34098567
Nat Commun. 2021 Jul 22;12(1):4469
pubmed: 34294704
Nature. 2021 Aug;596(7870):103-108
pubmed: 34153975
Cell. 2021 Aug 19;184(17):4380-4391.e14
pubmed: 34147139
Nat Commun. 2020 Sep 4;11(1):4420
pubmed: 32887876
Nat Commun. 2021 Jul 9;12(1):4223
pubmed: 34244518
Nature. 2022 Mar;603(7902):700-705
pubmed: 35104835
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Science. 2022 Mar 4;375(6584):1048-1053
pubmed: 35133176
Cell Rep Med. 2022 Jan 24;3(2):100527
pubmed: 35233548
Cell. 2021 Mar 4;184(5):1201-1213.e14
pubmed: 33571429
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
EMBO J. 2021 Oct 1;40(19):e107985
pubmed: 34302370
Nature. 2020 Dec;588(7839):682-687
pubmed: 33045718
Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1666-71
pubmed: 20080590
Elife. 2021 Dec 07;10:
pubmed: 34874007
J Med Virol. 2022 May;94(5):1808-1810
pubmed: 35043399
Sci Rep. 2016 Jan 21;6:19211
pubmed: 26791954
Nat Methods. 2020 Dec;17(12):1214-1221
pubmed: 33257830
3 Biotech. 2021 Feb;11(2):89
pubmed: 33500874
Nat Methods. 2017 Apr;14(4):331-332
pubmed: 28250466
Cell. 2020 Oct 29;183(3):739-751.e8
pubmed: 32991842
Nature. 2022 Feb;602(7898):676-681
pubmed: 35016198
Cell. 2020 Nov 12;183(4):1024-1042.e21
pubmed: 32991844
Science. 2022 Feb 25;375(6583):864-868
pubmed: 35076256
Nature. 2021 Nov;599(7883):114-119
pubmed: 34488225
Science. 2020 Dec 18;370(6523):1473-1479
pubmed: 33154106
Nature. 2021 Jul;595(7867):426-431
pubmed: 34126625
Bioinformatics. 2021 May 5;37(5):734-735
pubmed: 32805021
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Nature. 2021 May;593(7857):130-135
pubmed: 33684923
Cell. 2019 Feb 21;176(5):1026-1039.e15
pubmed: 30712865
Nature. 2022 Mar;603(7902):693-699
pubmed: 35062016
Cell. 2021 Apr 29;184(9):2332-2347.e16
pubmed: 33761326
Science. 2013 Nov 1;342(6158):592-8
pubmed: 24179220
Cell Host Microbe. 2021 Apr 14;29(4):508-515
pubmed: 33789086

Auteurs

Ryota Maeda (R)

Department of Haematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan. maeda@cognano.co.jp.
COGNANO Inc., Kyoto, 601-1255, Japan. maeda@cognano.co.jp.

Junso Fujita (J)

Graduate School of Frontier Biosciences, Osaka University, Osaka, 565-0871, Japan.
Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, 565-0871, Japan.

Yoshinobu Konishi (Y)

Department of Haematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.

Yasuhiro Kazuma (Y)

Department of Haematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.

Hiroyuki Yamazaki (H)

COGNANO Inc., Kyoto, 601-1255, Japan.
Shizuoka City Shizuoka Hospital, Shizuoka, 420-8630, Japan.

Itsuki Anzai (I)

Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, 565-0871, Japan.

Tokiko Watanabe (T)

Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, 565-0871, Japan.

Keishi Yamaguchi (K)

Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, 565-0871, Japan.

Kazuki Kasai (K)

COGNANO Inc., Kyoto, 601-1255, Japan.

Kayoko Nagata (K)

Department of Haematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.

Yutaro Yamaoka (Y)

Department of Microbiology and Molecular Biodefense Research, Yokohama City University Graduate School of Medicine, Yokohama, 236-0004, Japan.

Kei Miyakawa (K)

Department of Microbiology and Molecular Biodefense Research, Yokohama City University Graduate School of Medicine, Yokohama, 236-0004, Japan.

Akihide Ryo (A)

Department of Microbiology and Molecular Biodefense Research, Yokohama City University Graduate School of Medicine, Yokohama, 236-0004, Japan.

Kotaro Shirakawa (K)

Department of Haematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.

Kei Sato (K)

Division of System Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan.
Graduate School of Medicine, The University of Tokyo, Tokyo, 113-0033, Japan.
CREST, Japan Science and Technology Agency, Saitama, 332-0012, Japan.

Fumiaki Makino (F)

Graduate School of Frontier Biosciences, Osaka University, Osaka, 565-0871, Japan.
JEOL Ltd., Tokyo, 196-8558, Japan.

Yoshiharu Matsuura (Y)

Centre for Infectious Disease Education and Research, Osaka University, Osaka, 565-0871, Japan.
Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Osaka, 565-0871, Japan.

Tsuyoshi Inoue (T)

Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, 565-0871, Japan.

Akihiro Imura (A)

COGNANO Inc., Kyoto, 601-1255, Japan. akihiroimura@cognano.co.jp.

Keiichi Namba (K)

Graduate School of Frontier Biosciences, Osaka University, Osaka, 565-0871, Japan. keiichi@fbs.osaka-u.ac.jp.
JEOL YOKOGUSHI Research Alliance Laboratories, Osaka University, Osaka, 565-0871, Japan. keiichi@fbs.osaka-u.ac.jp.
RIKEN Centre for Biosystems Dynamics Research and SPring-8 Centre, Osaka, 565-0871, Japan. keiichi@fbs.osaka-u.ac.jp.

Akifumi Takaori-Kondo (A)

Department of Haematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan. atakaori@kuhp.kyoto-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH